Journal of Pancreatic Cancer

About This Journal:

  • Print This Page
  • Subscribe to an RSS Feed
My Liebert Connect

Sign up to stay informed--receive email notifications for this journal

Journal of Pancreatic Cancer

Editor-in-Chief: Charles J. Yeo, MD, FACS

• Online ISSN: 2475-3246 • Continuous Publication

Current Volume: 4

Aims & Scope

Featured Press Releases and Editorial Content

  • Researchers Identify Strong Prognostic Indicators of Survival Following Pancreatic Tumor Removal...Read More

Aims & Scope

Journal of Pancreatic Cancer is the only peer reviewed journal focused solely on pancreatic cancer. The Journal is international, and open access, publishing articles covering the clinical, translational and basic science of malignancies of the pancreas and the peripancreatic region.

Journal of Pancreatic Cancer provides a single open forum for communicating the advancement of science and treatments for pancreatic cancer. The Journal will be relevant for surgical oncologists, pancreatologists, gastroenterologists, radiation oncologists, medical oncologists, endocrinologists, pathologists, palliative care specialists, epidemiologists, immunologists or cancer researchers investigating problems and treatments for pancreatic cancer. The Journal publishes scientific studies on the clinical immunological, pathological, biological and other aspects of the disease. Topics considered range from molecular genetics to surgery and other therapeutic approaches and outcomes.

Journal of Pancreatic Cancer publishes under the Creative Commons Attribution 4.0 (CC BY) license and freely available online to ensure broad dissemination and participation.  All articles in the Journal are rapidly reviewed and published online. Journal of Pancreatic is fully NIH-, HHMI- and Wellcome Trust compliant.

Journal of Pancreatic Cancer coverage includes:

  • Pathological aspects
  • Surgical techniques
  • Innovative uses of novel technology or medical devices
  • Robotics
  • Genetic oncology
  • Chemotherapy and drug therapy
  • Radiation oncology
  • Epidemiological information
  • Molecular targeted therapy
  • Carcinogenesis
  • Alternative and complementary treatments
  • Early detection

Journal of Pancreatic Cancer is under the editorial leadership of Charles Yeo, MD, FACS, Samuel D. Gross Professor and Chair of the Department of Surgery at the Sidney Kimmel Medical College of Thomas Jefferson University.

Audience: Pancreatologists, gastroenterologists, surgical oncologists, radiation oncologists, pathologists, physicians, nurse practitioners, and palliative care providers


Benefits of publishing in Journal of Pancreatic Cancer:

  • High visibility, immediate and unrestricted online access to published articles
  • Rigorous and rapid peer review
  • Easy compliance with open access mandates
  • Authors retain copyright
  • Highly indexed – citation tracking and inclusion in bibliographic databases
  • Targeted email marketing

Publisher Contact

Sophie Mohin

Managing Editor
Mary Ann Liebert, Inc., publishers
140 Huguenot Street, 3rd Floor
New Rochelle, NY 10801
Phone: 914-740-2100

Indexed/Abstracted in:

EMBASE/Excerpta Medica; Google Scholar

The views, opinions, findings, conclusions and recommendations set forth in any Journal article are solely those of the authors of those articles and do not necessarily reflect the views, policy or position of the Journal, its Publisher, its editorial staff or any affiliated Societies and should not be attributed to any of them.

Recommended Publications

You may be interested in the following publications:

    Journal of Adolescent and Young Adult Oncology

    Journal of Adolescent and Young Adult Oncology

    The first cancer journal dedicated to the adolescent and young adult-aged oncology (AYAO) patient population. JAYAO is the only central forum for multidisiplinary, peer-reviewed articles, reviews, and research in the field.

    Lymphatic Research and Biology

    Lymphatic Research and Biology

    The latest original, peer-reviewed research in lymphatic biology and pathology from the world’s leading biomedical investigators.

    Cancer Biotherapy and Radiopharmaceuticals

    Cancer Biotherapy and Radiopharmaceuticals

    The established journal with over 30 years of peer-reviewed papers on new and innovative investigations of methods to improve cancer therapy. The Journal focuses on advancements in radioimmunotherapy and radiopharmaceuticals.

    Journal of Palliative Medicine

    Journal of Palliative Medicine

    The leading interdisciplinary journal reporting on the clinical, educational, legal, and ethical aspects of palliative care for patients in end of life or with intractable pain, focusing on improving quality of life.

Browse All Publications »